Clinical Trial Details
EORTC-40013-22012
Back to Clinical Trials Database
Randomised phase II/III study comparing gemcitabine followed by gemcitabine plus concomitant radiation (50.4 Gy) versus gemcitabine alone after curative pancreaticoduodenectomy for pancreatic head cancer
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 22-May-2003 Date Step1 close: 23-Jan-2007 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | EORTC Groups: 78 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00064207 |
| NCT number | NCT00064207 |
| EudraCT | 2005-000933-39 |
